Timelo Investment Management Inc. Gain Therapeutics, Inc. Transaction History
Timelo Investment Management Inc.
- $172 Million
- Q2 2024
A detailed history of Timelo Investment Management Inc. transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Timelo Investment Management Inc. holds 605,288 shares of GANX stock, worth $901,879. This represents 0.45% of its overall portfolio holdings.
Number of Shares
605,288Holding current value
$901,879% of portfolio
0.45%Shares
1 transactions
Others Institutions Holding GANX
# of Institutions
31Shares Held
3.75MCall Options Held
0Put Options Held
0-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$876,7300.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$843,5330.04% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL450KShares$670,5000.0% of portfolio
-
Hohimer Wealth Management, LLC330KShares$491,7000.1% of portfolio
-
Geode Capital Management, LLC Boston, MA184KShares$273,7660.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $17.7M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...